| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.4 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.048 | 0.4 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |